AUSTAR LIFESCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.95 HKD | -6.86% |
|
-7.77% | -39.10% |
| Mar. 26 | Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 22 | Austar Lifesciences to Swing to Loss; Shares Drop | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Austar Lifesciences Limited is principally engaged in the provision of integrated engineering solutions to pharmaceutical manufactures and research institutes and the manufacture and distribution of pharmaceutical equipment and consumables in China. The Company operates its business through six segments: liquid and bioprocess system segment, clean room and automation control and monitoring system segment, powder and solid system segment, good manufacturing practice (GMP) compliance service segment, life science consumables segment and distribution and agency of pharmaceutical equipment segment.
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -39.10% | 66.72M | |
| -2.73% | 186B | |
| -2.20% | 107B | |
| -4.08% | 67.57B | |
| +5.99% | 50.7B | |
| +15.32% | 47.2B | |
| -0.45% | 39.72B | |
| +6.60% | 27.48B | |
| -1.11% | 25.65B | |
| -0.76% | 24.82B |
- Stock Market
- Equities
- 6118 Stock
- News Austar Lifesciences Limited
- Austar Lifesciences : to Log Higher H1 Net Profit
